Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew Moe

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Translational Andrology and Urology|January 18, 2021
Transrectal ultrasound biopsy of the prostate: does it still have a role in prostate cancer diagnosis?Andrew Moe, Dickon Hayne
Urology Case Reports|October 26, 2020
Open partial nephrectomy for a collision renal cell carcinoma in a transplant kidney: A case reportAndrew Moe, Isaac Thyer, Rajalingam Sinniah, et al.
Conference Proceedings : ... Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual Conference|February 3, 2007
Enhanced fluorescence emission using a programmable, reconfigurable LED-array based light sourceAndrew Moe, Naureen Banani, Linda Lee, et al.
Folia Medica|July 20, 2022
Anterior pelvic exenteration and synchronous bilateral nephroureterectomy for BK polyoma virus induced urothelial carcinoma of the bladder: A case reportOliver Oey, Pravin Viswambaram, Andrew Moe, et al.
ANZ Journal of Surgery|September 25, 2020
'One Stop Prostate Clinic': prospective analysis of 1000 men attending a public same-day prostate cancer assessment and/or diagnostic clinicCynthia Hawks, Andrew Moe, Steve McCombie, et al.
BJU International|May 7, 2021
A phase I open label dose-escalation study to evaluate the tolerability, safety and immunological efficacy of sub-urothelial durvalumab injection in adults with muscle-invasive or high-risk non-muscle-invasive bladder cancer (SUBDUE-1, SUB-urothelial DUrvalumab injection-1 study): clinical trial protocolAndrew Moe, Elizabeth Liow, Andrew Redfern, et al.
Asia-Pacific Journal of Clinical Oncology|January 20, 2023
Fremantle protocol: Multicenter clinical outcomes for a pragmatic protocol for intravesical bacillus Calmette-GuerinKuok Liang Tan, Pravin Viswambaram, Stephen McCombie, et al.
Journal of Tissue Viability|September 3, 2017
Adaptation of a MR imaging protocol into a real-time clinical biometric ultrasound protocol for persons with spinal cord injury at risk for deep tissue injury: A reliability studyJillian M Swaine, Andrew Moe, William Breidahl, et al.
BJU International|March 12, 2024
The SUB-urothelial DUrvalumab InjEction-1 (SUBDUE-1) trial: first-in-human trial in patients with bladder cancerDickon Hayne, Katherine Ong, Nicole Swarbrick, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Translational Andrology and Urology|January 18, 2021
Transrectal ultrasound biopsy of the prostate: does it still have a role in prostate cancer diagnosis?Andrew Moe, Dickon Hayne
Urology Case Reports|October 26, 2020
Open partial nephrectomy for a collision renal cell carcinoma in a transplant kidney: A case reportAndrew Moe, Isaac Thyer, Rajalingam Sinniah, et al.
Conference Proceedings : ... Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual Conference|February 3, 2007
Enhanced fluorescence emission using a programmable, reconfigurable LED-array based light sourceAndrew Moe, Naureen Banani, Linda Lee, et al.
Folia Medica|July 20, 2022
Anterior pelvic exenteration and synchronous bilateral nephroureterectomy for BK polyoma virus induced urothelial carcinoma of the bladder: A case reportOliver Oey, Pravin Viswambaram, Andrew Moe, et al.
ANZ Journal of Surgery|September 25, 2020
'One Stop Prostate Clinic': prospective analysis of 1000 men attending a public same-day prostate cancer assessment and/or diagnostic clinicCynthia Hawks, Andrew Moe, Steve McCombie, et al.
BJU International|May 7, 2021
A phase I open label dose-escalation study to evaluate the tolerability, safety and immunological efficacy of sub-urothelial durvalumab injection in adults with muscle-invasive or high-risk non-muscle-invasive bladder cancer (SUBDUE-1, SUB-urothelial DUrvalumab injection-1 study): clinical trial protocolAndrew Moe, Elizabeth Liow, Andrew Redfern, et al.
Asia-Pacific Journal of Clinical Oncology|January 20, 2023
Fremantle protocol: Multicenter clinical outcomes for a pragmatic protocol for intravesical bacillus Calmette-GuerinKuok Liang Tan, Pravin Viswambaram, Stephen McCombie, et al.
Journal of Tissue Viability|September 3, 2017
Adaptation of a MR imaging protocol into a real-time clinical biometric ultrasound protocol for persons with spinal cord injury at risk for deep tissue injury: A reliability studyJillian M Swaine, Andrew Moe, William Breidahl, et al.
BJU International|March 12, 2024
The SUB-urothelial DUrvalumab InjEction-1 (SUBDUE-1) trial: first-in-human trial in patients with bladder cancerDickon Hayne, Katherine Ong, Nicole Swarbrick, et al.
Pageof 1